Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal timing of midazolam and fentanyl administration for smooth colonoscopy
TCTR20260820010Active, not recruiting
- Sponsor
- Rueangsiri Panuwet
- Start
- Oct 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam and fentanyl in None (2 arms), sponsored by Rueangsiri Panuwet. Primary endpoints: Optimal timing of midazolam before colonoscopy and Optimal timing of fentanyl before colonoscopy. Started Oct 2025; status: active, not recruiting.
02
Drugs
midazolamfentanyl
Beyond the preview
Go deeper on TCTR20260820010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260820010.